Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 390

CodeSignal transmits details of $25m series B

Capital One Ventures put up a share of the funding to help bring IT assessmennt software provider CodeSignal's overall funding to more than $37m.

Dec 9, 2020

Skyflow soars with series A funding

MS&AD Ventures-backed data privacy API developer has now raised at least $25m in funding to date, with Canvas Ventures leading its $17.5m series A.

Dec 9, 2020

NextEra picks up eIQ Mobility

Schneider Electric Ventures has scored an exit having backed the EV fleet services provider's seed round in February 2019.

Dec 9, 2020

EquipmentShare twigs to $11m Branch round

EquipmentShare has put its weight behind Branch Technology, an operator of industrial-scale 3D printers for making composite building materials.

Dec 9, 2020

TerraCycle loops in corporates for $25m

Corporate investors including Suez, Aptar, Sky Ocean Ventures, P&G and Nestlé have backed TerraCycle, the operator of consumer product recycling service Loop.

Dec 9, 2020

At-Bay harbours corporates in $34m series C

Munich Re Ventures and M12 helped bring the digital insurance portal's lifetime funding to $91m having already backed its series B round earlier this year.

Dec 9, 2020

Synctera draws funding in Diagram-backed round

Power Corporation-allied Diagram Ventures helped Synctera pick up $12.4m in a round announced as the financial technology marketplace publicly launched.

Dec 9, 2020

Gupta unveils PruVen fund

Prior to founding venture firm PruVen in the summer, Ramneek Gupta had co-founded the venture investing efforts at financial services firm Citi. 

Dec 9, 2020

DoorDash lets in $3.37bn through IPO

SoftBank Vision Fund is the largest investor in the food delivery service, which has priced an upsized initial public offering roughly doubling its valuation six months ago.

Dec 9, 2020

Silverback swells IPO to near $278m

The underwriters have taken up the over-allotment option in BMS and Celgene-backed oncology drug developer Silverback's initial public offering.

Dec 9, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here